Open Monoclonal Technology, Inc. (OMT) is a leader in genetic engineering of animals for development of human therapeutic antibodies. The company's antibody platforms, OmniRat®, OmniMouse® and OmniFlic have broad freedom to operate and use technology protected by new patents and patent applications. They are available for licensing worldwide for all targets and indications.
| Company | Open Monoclonal Technology, Inc. | |
| Headquarters Address: | 2747 Ross Road | |
| Palo Alto, CA 93404 | ||
| Main Telephone: | 775-420-7750 | |
| Website: | www.omtinc.net | |
| Type of Organization: | Private | |
| Industry: | Biotechnology | |
| Key Executives: | CEO: Roland Buelow | |
| CBO: Brian Lundstrom | ||
| CFO: Sandra Tucher | ||
| Public Relations | ||
| Contact: | Brian Lundstrom | |
| Phone: | +1-775-420-7750 | |
| Email: | bl@omtinc.net |
© 2013 Business Wire
